Skip to main content
OpenTrials

Clinical trial condition

Leukocyte Disorders

Explore clinical trials studying Leukocyte Disorders. Study availability and eligibility vary by location and protocol.

737 public trials 106 recruiting studies
Refine in advanced search Browse all conditions

Leukocyte Disorders trial results

Completed

Safety and Efficacy Study of Flebogamma 5% DIF IGIV in Pediatric Subjects

NCT00634569

Conditions
Blood Coagulation Disorders, Blood Coagulation Disorders, Inherited, Blood Protein Disorders, +18 more
Locations
  • University of South Florida St. Petersburg, Florida, United States
  • Family Allergy & Asthma Center, PC Atlanta, Georgia, United States
  • Rush University Medical Center Chicago, Illinois, United States
  • The Allergy and Asthma Center Fort Wayne, Indiana, United States
View Trial Details
Completed

EoE(Eosinophilic Esophagitis)

NCT01999439

Conditions
Deglutition Disorders, Digestive System Diseases, Dysphagia, +14 more
Locations
  • University of Michigan C. S. Mott Childrens Hospital Ann Arbor, Michigan, United States
View Trial Details
Completed

Dose-finding Study of Empegfilgrastim for Neutropenia Prophylaxis in Patients With Breast Cancer

NCT01569087

Conditions
Agranulocytosis, Breast Diseases, Breast Neoplasms, +12 more
Locations
  • Arkhangelsk District Clinical Oncology Dispensary Arkhangelsk, Russia
  • Perm Region Oncology Dispensary Perm, Russia
  • N.N.Petrov Oncology Research Center Saint Petersburg, Russia
  • Russian scientific center of radiology and surgery technologies Saint Petersburg, Russia
View Trial Details
Completed

Study of the Efficacy and Safety of Empegfilgrastim for Neutropenia Prophylaxis in Breast Cancer Patients

NCT02104830

Conditions
Agranulocytosis, Breast Diseases, Breast Neoplasms, +12 more
Locations
  • Arkhangelsk District Clinical Oncology Dispensary Arkhangelsk, Russia
  • Clinical Hospital at Chelyabinsk Railway Station Chelyabinsk, Russia
  • State public health institution "Republican Clinical Oncology Dispensary" of the Ministry of Health of the Republic of Tatarstan Kazan', Russia
  • Non-governmental healthcare institution "Central Clinical Hospital № 2 Semashko" JSC "Russian Railways" Moscow, Russia
View all 13 locations
View Trial Details
Completed

Efficacy and Safety Study of Reslizumab to Treat Eosinophilic Esophagitis in Subjects Aged 5 to 18 Years

NCT00538434

Conditions
Deglutition Disorders, Digestive System Diseases, Eosinophilia, +13 more
Locations
  • The Children's Hospital of Alabama Birmingham, Alabama, United States
  • University of Arizona Dept. of Pediatrics Tucson, Arizona, United States
  • Arkansas Children's Hospital/University of Arkansas for Medical Sciences Little Rock, Arkansas, United States
  • Kaiser Permanente Hospital- Pediatric Gastroenterology Hayward, California, United States
View all 37 locations
View Trial Details

Related conditions